Form 8-K FRACTYL HEALTH, INC. For: Jul 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall St futures climb ahead of this week's megacap earnings
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threatÂ
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Wall St futures climb ahead of this week's megacap earnings
- IREN raises 2026 revenue target to $4bn after $2.8bn in contracts
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threatÂ
- AMC Entertainment posts record quarterly revenue and EBITDA in Q2 2026
H.C. Wainwright Reiterates Buy Rating on Fractyl Health Inc (GUTS)
July 15, 2026 12:16 PM EDTH.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $8.00 price target on Fractyl Health Inc (NASDAQ: GUTS).
The analyst comments "Overall, we believe that REMAIN-1 midpoint cohort data demonstrate Revita-mediated durable and substantial weight retention at one year without the need for ongoing medication. We expect these observations to be reproduced and valudated in the ongoing, larger pivotal cohort of patients. Topline six-month randomized data are... More
